1. Home/
  2. Compounds/
  3. SNX-2112:bortezomib (250:1 mol/mol)

SNX-2112:bortezomib (250:1 mol/mol)

Synonyms

SourcesNames Used
CTRPv2SNX-2112:bortezomib (250:1 mol/mol)
PharmacoGx SNX-2112:bortezomib (250:1 mol/mol)

FDA Approval Status

Not Approved
Dataset Select
Download Data as CSV

Top molecular features associated with response to SNX-2112:bortezomib (250:1 mol/mol)


Feature TypeStandardized
Nominal ANOVA
mRNA SGCE CTRPv2 pan-cancer AAC -0.097 0.01
mRNA RCVRN CTRPv2 pan-cancer AAC 0.081 0.01
mRNA SPRY2 CTRPv2 pan-cancer AAC 0.091 0.01
mRNA HAUS2 CTRPv2 pan-cancer AAC 0.083 0.01
mRNA RMI1 CTRPv2 pan-cancer AAC 0.085 0.01
mRNA ECE1 CTRPv2 pan-cancer AAC -0.093 0.01
mRNA TH CTRPv2 pan-cancer AAC -0.093 0.01
mRNA SNX4 CTRPv2 pan-cancer AAC 0.083 0.01
mRNA PAM16 CTRPv2 pan-cancer AAC 0.085 0.01
mRNA ARL5A CTRPv2 pan-cancer AAC 0.085 0.01
Download CSV